drugset / Trial / NCT02239445

Intranasal Dexmedetomidine VS Oral Chloral Hydrate for Rescue Sedation During Magnetic Resonance Imaging

NCT02239445

Phase 4 Completed 158 enrolled Guangzhou Women and Children's Medical Center
RandomizedParallel-groupDouble-blind

Summary

The purpose of this investigation was to test the hypothesis that intranasal dexmedetomidine is as effective as second dose of oral chloral hydrate for rescue sedation in infant age between 1 and 6 months who were not adequately sedated following initial dose of chloral hydrate.

Timeline

Start
2014-09
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chloral Hydrate Small molecule 0.25 mg/kg Oral
Subject Dexmedetomidine Other / unclassified 1 ug/kg Intranasal
Subject Dexmedetomidine Other / unclassified 2 ug/kg Intranasal

Indications

No indication recorded.